• 1. Articulate  how to identify high risk patients based on genomic analysis

  • 2. Verbalize how to integrate genomic analysis into Management decisions

  • 3. List risks and benefits of population screening for inherited cancer risks


Session date: 
11/18/2016 - 8:00am to 9:00am CST
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Olufunmilayo I. Olopade, MD, FACP